rs2234331
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_018943.3(TUBA8):c.383C>T(p.Ala128Val) variant causes a missense change. The variant allele was found at a frequency of 0.0108 in 1,614,118 control chromosomes in the GnomAD database, including 128 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Genomes: 𝑓 0.0075 ( 9 hom., cov: 32)
Exomes 𝑓: 0.011 ( 119 hom. )
Consequence
TUBA8
NM_018943.3 missense
NM_018943.3 missense
Scores
1
4
13
Clinical Significance
Conservation
PhyloP100: 5.26
Genes affected
TUBA8 (HGNC:12410): (tubulin alpha 8) This gene encodes a member of the alpha tubulin protein family. Alpha tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. Mutations in this gene are associated with polymicrogyria and optic nerve hypoplasia. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 22-18126361-C-T is Benign according to our data. Variant chr22-18126361-C-T is described in ClinVar as [Benign]. Clinvar id is 160173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-18126361-C-T is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 9 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBA8 | NM_018943.3 | c.383C>T | p.Ala128Val | missense_variant | 4/5 | ENST00000330423.8 | NP_061816.1 | |
TUBA8 | NM_001193414.2 | c.185C>T | p.Ala62Val | missense_variant | 4/5 | NP_001180343.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBA8 | ENST00000330423.8 | c.383C>T | p.Ala128Val | missense_variant | 4/5 | 1 | NM_018943.3 | ENSP00000333326.3 | ||
ENSG00000288683 | ENST00000474897.6 | n.*273C>T | non_coding_transcript_exon_variant | 8/9 | 5 | ENSP00000434235.2 | ||||
ENSG00000288683 | ENST00000474897.6 | n.*273C>T | 3_prime_UTR_variant | 8/9 | 5 | ENSP00000434235.2 |
Frequencies
GnomAD3 genomes AF: 0.00750 AC: 1141AN: 152184Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
1141
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00709 AC: 1780AN: 251010Hom.: 5 AF XY: 0.00733 AC XY: 995AN XY: 135800
GnomAD3 exomes
AF:
AC:
1780
AN:
251010
Hom.:
AF XY:
AC XY:
995
AN XY:
135800
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0111 AC: 16251AN: 1461816Hom.: 119 Cov.: 31 AF XY: 0.0109 AC XY: 7936AN XY: 727208
GnomAD4 exome
AF:
AC:
16251
AN:
1461816
Hom.:
Cov.:
31
AF XY:
AC XY:
7936
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00749 AC: 1140AN: 152302Hom.: 9 Cov.: 32 AF XY: 0.00698 AC XY: 520AN XY: 74470
GnomAD4 genome
AF:
AC:
1140
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
520
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
52
ALSPAC
AF:
AC:
53
ESP6500AA
AF:
AC:
14
ESP6500EA
AF:
AC:
97
ExAC
AF:
AC:
849
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 16, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | ENSG00000280007: BS1, BS2; TUBA8: BS1, BS2 - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 02, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 23, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
.;D;D
Sift4G
Benign
T;T;T
Polyphen
0.039, 0.22
.;B;B
Vest4
MVP
MPC
0.27
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 17
Find out detailed SpliceAI scores and Pangolin per-transcript scores at